Literature DB >> 26797721

Spatial distribution of syndesmophytes along the vertebral rim in ankylosing spondylitis: preferential involvement of the posterolateral rim.

Sovira Tan1, Abhijit Dasgupta1, Jianhua Yao2, John A Flynn3, Lawrence Yao2, Michael M Ward1.   

Abstract

OBJECTIVE: Syndesmophytes in ankylosing spondylitis (AS) can occur anywhere along the vertebral rim, but little is known about how and where they develop, and particularly if they first form in certain locations along the rim. This information might provide clues to their aetiology. We examined the spatial distribution of syndesmophytes in the thoracolumbar spine in patients with AS using CT.
METHODS: We performed lumbar spine CT scans in 50 patients and used a validated computer algorithm to measure syndesmophyte heights in six intervertebral disc spaces. We measured heights every five radial degrees around the rim of each superior and inferior vertebral endplate.
RESULTS: Syndesmophytes were observed in 208 of 296 intervertebral disc spaces. Both ascending and descending syndesmophytes were non-randomly distributed along the vertebral rim (p<0.0001 for deviation from uniform distribution). Syndesmophytes occurred most often at the posterolateral vertebral rim, and least commonly at the posterior rim and anterior rim. In disc spaces with only small isolated syndesmophytes, these were also most likely to occur at the posterolateral rim. Syndesmophyte distribution varied with the vertebral level. Localisation at the posterolateral rim was most pronounced at T10-T11, T12-T12 and T12-L1, while L2-L3 and L3-L4 exhibited little localisation.
CONCLUSIONS: Syndesmophytes are not randomly distributed around the vertebral rim, as might be expected if they develop solely in response to inflammation. Rather, they preferentially occur, and likely develop first, at the posterolateral rim. Studying factors that can lead to this pattern may help elucidate how syndesmophytes develop. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Ankylosing Spondylitis; Outcomes research; Spondyloarthritis

Mesh:

Year:  2016        PMID: 26797721      PMCID: PMC5072453          DOI: 10.1136/annrheumdis-2015-208802

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  A simple permutation-type method for testing circular uniformity with correlated angular measurements.

Authors:  D A Follmann; M A Proschan
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

2.  Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders.

Authors:  M Benjamin; H Toumi; D Suzuki; S Redman; P Emery; D McGonagle
Journal:  Arthritis Rheum       Date:  2007-01

3.  Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis.

Authors:  Michael M Ward; John D Reveille; Thomas J Learch; John C Davis; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2008-06-15

4.  Mechanical influences in bone remodeling. Experimental research on Wolff's law.

Authors:  A Chamay; P Tschantz
Journal:  J Biomech       Date:  1972-03       Impact factor: 2.712

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter.

Authors:  Astrid J B Wanders; Robert B M Landewé; Anneke Spoorenberg; Maxime Dougados; Sjef van der Linden; Herman Mielants; Hille van der Tempel; Désirée M F M van der Heijde
Journal:  Arthritis Rheum       Date:  2004-08

7.  Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27.

Authors:  D G Spencer; W M Park; H M Dick; S N Papazoglou; W W Buchanan
Journal:  J Rheumatol       Date:  1979 May-Jun       Impact factor: 4.666

8.  The three column spine and its significance in the classification of acute thoracolumbar spinal injuries.

Authors:  F Denis
Journal:  Spine (Phila Pa 1976)       Date:  1983 Nov-Dec       Impact factor: 3.468

9.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12

10.  Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells.

Authors:  Peggy Jacques; Stijn Lambrecht; Eveline Verheugen; Elin Pauwels; George Kollias; Maria Armaka; Marleen Verhoye; Annemie Van der Linden; Rik Achten; Rik J Lories; Dirk Elewaut
Journal:  Ann Rheum Dis       Date:  2013-08-06       Impact factor: 19.103

View more
  3 in total

Review 1.  Better Quantification of Syndesmophyte Growth in Axial Spondyloarthritis.

Authors:  Michael M Ward; Sovira Tan
Journal:  Curr Rheumatol Rep       Date:  2018-06-21       Impact factor: 4.592

2.  Distribution of Acute and Chronic Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis.

Authors:  Churong Lin; Dong Liu; Budian Liu; Jieruo Gu
Journal:  Int J Gen Med       Date:  2022-01-04

3.  Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trial.

Authors:  Susanne J Pedersen; Mikkel Østergaard; Simon Krabbe; Inge J Sørensen; Bente Jensen; Jakob M Møller; Lone Balding; Ole R Madsen; Robert G W Lambert; Walter P Maksymowych
Journal:  RMD Open       Date:  2018-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.